Genetic factors in type 1 diabetes

A complex disease

Research output: Contribution to journalReview article

Abstract

Insulin-dependent diabetes mellitus (IDDM or type 1 diabetes) is a complex (multifactorial) disease, in which the expression of the disease phenotype is influenced by a large number of genes as well as environmental factors. Genome wide linkage analyses indicate that the most important genetic factors in IDDM are encoded in the HLA region on chromosome 6p21, which, indeed, contains multiple susceptibility genes. The HLA-DR and -DQ molecules are important genetic factors and they may confer susceptible, neutral, or protective effects on risk for IDDM. The overall risk may be determined by the counter-balancing effect of all HLA class II molecules in an individual. Therefore, HLA genotypes, instead of individual alleles, should be considered for risk prediction. A second IDDM locus has been mapped to the VNTR (variable number of tandem repeat) at the 5' end of the insulin (INS) gene on chromosome 11p15. The size and sequence of this repetitive element play a role in the regulation of INS expression in the thymus, suggesting that tolerance induction to insulin may be relevant to the pathogenesis of IDDM. Recent linkage studies also revealed 13 additional genomic regions that may contain IDDM susceptibility genes. Only four of these intervals (IDDM4 on 11q,IDDM5 on 6q25,IDDM8, and IDDM12 on 2q33) have been confirmed in multiple studies. One of the confirmed intervals (IDDM12) has been localized to a genomic region of less than 100 kb which contains the immuno-regulatory molecule CTLA4. The identified genetic factors are already useful for IDDM prediction in relatives of diabetic patients and in the general population. However, these and additional genetic markers in combination with immunological markers will provide the most specific and sensitive tests for the prediction of IDDM.

Original languageEnglish (US)
Pages (from-to)272-281
Number of pages10
JournalJournal of Clinical Ligand Assay
Volume21
Issue number3
StatePublished - Sep 1 1998
Externally publishedYes

Fingerprint

Medical problems
Type 1 Diabetes Mellitus
Genes
Insulin
Chromosomes
Molecules
Thymus
Minisatellite Repeats
Nucleic Acid Repetitive Sequences
HLA-DR Antigens
HLA-DQ Antigens
Genetic Markers
Thymus Gland
Alleles
Genotype
Genome
Phenotype

Keywords

  • Association analysis
  • Autoimmune diseases
  • CTLA4
  • Disease risk
  • HLA
  • IDDM
  • Insulin
  • Linkage analysis
  • Linkage disequilibrium
  • Type 1 diabetes
  • VNTR

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology

Cite this

Genetic factors in type 1 diabetes : A complex disease. / She, Jin-Xiong.

In: Journal of Clinical Ligand Assay, Vol. 21, No. 3, 01.09.1998, p. 272-281.

Research output: Contribution to journalReview article

@article{eb692047d80a4296a387808daeced091,
title = "Genetic factors in type 1 diabetes: A complex disease",
abstract = "Insulin-dependent diabetes mellitus (IDDM or type 1 diabetes) is a complex (multifactorial) disease, in which the expression of the disease phenotype is influenced by a large number of genes as well as environmental factors. Genome wide linkage analyses indicate that the most important genetic factors in IDDM are encoded in the HLA region on chromosome 6p21, which, indeed, contains multiple susceptibility genes. The HLA-DR and -DQ molecules are important genetic factors and they may confer susceptible, neutral, or protective effects on risk for IDDM. The overall risk may be determined by the counter-balancing effect of all HLA class II molecules in an individual. Therefore, HLA genotypes, instead of individual alleles, should be considered for risk prediction. A second IDDM locus has been mapped to the VNTR (variable number of tandem repeat) at the 5' end of the insulin (INS) gene on chromosome 11p15. The size and sequence of this repetitive element play a role in the regulation of INS expression in the thymus, suggesting that tolerance induction to insulin may be relevant to the pathogenesis of IDDM. Recent linkage studies also revealed 13 additional genomic regions that may contain IDDM susceptibility genes. Only four of these intervals (IDDM4 on 11q,IDDM5 on 6q25,IDDM8, and IDDM12 on 2q33) have been confirmed in multiple studies. One of the confirmed intervals (IDDM12) has been localized to a genomic region of less than 100 kb which contains the immuno-regulatory molecule CTLA4. The identified genetic factors are already useful for IDDM prediction in relatives of diabetic patients and in the general population. However, these and additional genetic markers in combination with immunological markers will provide the most specific and sensitive tests for the prediction of IDDM.",
keywords = "Association analysis, Autoimmune diseases, CTLA4, Disease risk, HLA, IDDM, Insulin, Linkage analysis, Linkage disequilibrium, Type 1 diabetes, VNTR",
author = "Jin-Xiong She",
year = "1998",
month = "9",
day = "1",
language = "English (US)",
volume = "21",
pages = "272--281",
journal = "Journal of Clinical Ligand Assay",
issn = "1081-1672",
publisher = "Clinical Ligand Assay Society Inc.",
number = "3",

}

TY - JOUR

T1 - Genetic factors in type 1 diabetes

T2 - A complex disease

AU - She, Jin-Xiong

PY - 1998/9/1

Y1 - 1998/9/1

N2 - Insulin-dependent diabetes mellitus (IDDM or type 1 diabetes) is a complex (multifactorial) disease, in which the expression of the disease phenotype is influenced by a large number of genes as well as environmental factors. Genome wide linkage analyses indicate that the most important genetic factors in IDDM are encoded in the HLA region on chromosome 6p21, which, indeed, contains multiple susceptibility genes. The HLA-DR and -DQ molecules are important genetic factors and they may confer susceptible, neutral, or protective effects on risk for IDDM. The overall risk may be determined by the counter-balancing effect of all HLA class II molecules in an individual. Therefore, HLA genotypes, instead of individual alleles, should be considered for risk prediction. A second IDDM locus has been mapped to the VNTR (variable number of tandem repeat) at the 5' end of the insulin (INS) gene on chromosome 11p15. The size and sequence of this repetitive element play a role in the regulation of INS expression in the thymus, suggesting that tolerance induction to insulin may be relevant to the pathogenesis of IDDM. Recent linkage studies also revealed 13 additional genomic regions that may contain IDDM susceptibility genes. Only four of these intervals (IDDM4 on 11q,IDDM5 on 6q25,IDDM8, and IDDM12 on 2q33) have been confirmed in multiple studies. One of the confirmed intervals (IDDM12) has been localized to a genomic region of less than 100 kb which contains the immuno-regulatory molecule CTLA4. The identified genetic factors are already useful for IDDM prediction in relatives of diabetic patients and in the general population. However, these and additional genetic markers in combination with immunological markers will provide the most specific and sensitive tests for the prediction of IDDM.

AB - Insulin-dependent diabetes mellitus (IDDM or type 1 diabetes) is a complex (multifactorial) disease, in which the expression of the disease phenotype is influenced by a large number of genes as well as environmental factors. Genome wide linkage analyses indicate that the most important genetic factors in IDDM are encoded in the HLA region on chromosome 6p21, which, indeed, contains multiple susceptibility genes. The HLA-DR and -DQ molecules are important genetic factors and they may confer susceptible, neutral, or protective effects on risk for IDDM. The overall risk may be determined by the counter-balancing effect of all HLA class II molecules in an individual. Therefore, HLA genotypes, instead of individual alleles, should be considered for risk prediction. A second IDDM locus has been mapped to the VNTR (variable number of tandem repeat) at the 5' end of the insulin (INS) gene on chromosome 11p15. The size and sequence of this repetitive element play a role in the regulation of INS expression in the thymus, suggesting that tolerance induction to insulin may be relevant to the pathogenesis of IDDM. Recent linkage studies also revealed 13 additional genomic regions that may contain IDDM susceptibility genes. Only four of these intervals (IDDM4 on 11q,IDDM5 on 6q25,IDDM8, and IDDM12 on 2q33) have been confirmed in multiple studies. One of the confirmed intervals (IDDM12) has been localized to a genomic region of less than 100 kb which contains the immuno-regulatory molecule CTLA4. The identified genetic factors are already useful for IDDM prediction in relatives of diabetic patients and in the general population. However, these and additional genetic markers in combination with immunological markers will provide the most specific and sensitive tests for the prediction of IDDM.

KW - Association analysis

KW - Autoimmune diseases

KW - CTLA4

KW - Disease risk

KW - HLA

KW - IDDM

KW - Insulin

KW - Linkage analysis

KW - Linkage disequilibrium

KW - Type 1 diabetes

KW - VNTR

UR - http://www.scopus.com/inward/record.url?scp=0032463488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032463488&partnerID=8YFLogxK

M3 - Review article

VL - 21

SP - 272

EP - 281

JO - Journal of Clinical Ligand Assay

JF - Journal of Clinical Ligand Assay

SN - 1081-1672

IS - 3

ER -